Clinical Trials at Cancer Partners of Nebraska
As of August 2026, 11 paid clinical trials are recruiting at Cancer Partners of Nebraska, located at 4101 TIGER LILY RD STE 100, LINCOLN, NE 68516-5587, phone (402) 420-7000 in Lincoln, Nebraska. Active studies at this site cover conditions such as Non-Small Cell Lung Cancer, Schizophrenia and Heart Failure. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
11 clinical trials at Cancer Partners of Nebraska
·Clear filters·Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Common conditions studied in Lincoln
- Non-Small Cell Lung Cancer (6 active studies)
- Schizophrenia (6 active studies)
- Heart Failure (5 active studies)
- Healthy (4 active studies)
- Non-small Cell Lung Cancer (4 active studies)
- Carcinoma, Non-Small-Cell Lung (NSCLC) (3 active studies)
Leading research sponsors in Lincoln
- Merck Sharp & Dohme LLC
- Pfizer
- AstraZeneca
- AbbVie
- Alkermes, Inc.
Frequently asked questions
How many paid clinical trials are currently recruiting in Lincoln?
There are approximately 128 recruiting clinical trials in Lincoln, Nebraska listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Lincoln pay participants?
Most recruiting trials in Lincoln compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Lincoln?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Lincoln?
The most common conditions under active study in Lincoln include Non-Small Cell Lung Cancer (6), Schizophrenia (6), Heart Failure (5), Healthy (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Lincoln?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Lincoln on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Lincoln?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Lincoln?
Recruiting research sites in Lincoln include Cancer Partners of Nebraska, Bryan Heart, NHO Revive Research Institute, LLC, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Lincoln right now?
The largest active categories in Lincoln are Cancer & tumors (38), Cardiovascular (13), Mental health & behavior (10). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Cancer Partners of Nebraska?
Cancer Partners of Nebraska is located at 4101 TIGER LILY RD STE 100, LINCOLN, NE 68516-5587. Use the Google Maps link in the intro above to get directions.
How do I contact Cancer Partners of Nebraska?
You can reach Cancer Partners of Nebraska by phone at (402) 420-7000. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.